---
$id: https://graph.org.ai/products/commodity/51372023
$type: Product
source: UNSPSC
code: "51372023"
title: "Butorphanol tartrate"
class: "51372000"
classTitle: "Controlled substance analgesic morphinans"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butorphanol tartrate

**UNSPSC Code**: 51372023
**Class**: [Controlled substance analgesic morphinans](Controlled substance analgesic morphinans.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid analgesic with the molecular formula C21H29NO2.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2L7I72RUHN, chemically known as l-n-cyclobutylmethyl-3,14-dihydroxymorphinan tartrate salt but more generally known as butorphanol tartrate, which bears US NIH Compound Identifier 5462346. European Medicines Agency schedules Butorphanol tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00920MIG. Most nations, for tariff and trade purposes, schedule butorphanol tartrate under HS 29334990 and SITC 51575. As of Q4 2014, BUTORPHANOL TARTRATE remains US FDA's Preferred Term for this commodity. Butorphanol tartrate bears US NLM identifiers UMLS ID C0038119 and NCI Concept Code C61658. SMILES: C1CC2C(CC1O)[C@@]34CCCC[C@]3([C@@H](C2)N(CC4)CC5CCC5)O.[C@H]([C@@H](C(=O)O)O)(C(=O)O)O.

